PRDX4 and neoplasm: In cancers, PRDX4 is frequently overexpressed in multiple tumor types, including breast, prostate, ovarian, colorectal, lung, and gastric cancers, and is associated with tumorigenesis, therapeutic resistance, metastasis, and recurrence [106,107,108,109,110].